Delivery Order SPE2DB24D1007-SPE2DB24FCAFH
Award Date
8/23/24
Potential Completion Date
9/16/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $16,019.90 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROQUAD VIALS. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide....
The Defense Logistics Agency (DLA) awarded a $14,134.86 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of PROQUAD VIALS. This contract has no set-aside designation and is scheduled for completion by September 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these critical medical supplies to support various government agencies and healthcare programs. The company has been awarded numerous federal contracts by the DLA and...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $12,537.75 to AmerisourceBergen Drug Corp's Corporate Office division. The contract, which does not have a set-aside designation, is for the supply of PROQUAD VIALS and has an ultimate completion date of August 15, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been a significant supplier of pharmaceutical products and medical supplies to various federal agencies,...
The Defense Logistics Agency (DLA) awarded a $4,711.62 firm fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of PROQUAD VIALS. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide these medical supplies to support various government agencies and healthcare programs, including military treatment facilities and veterans' hospitals. This delivery order is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,575.60 firm fixed price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Medical Troop Support to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,159.95 firm fixed-price contract is for the delivery of PROQUAD VIALS, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded multiple Indefinite Delivery Contracts (IDCs) by federal agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,654.33, is for the delivery of PROQUAD VIALS medical products. It is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2025. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,654.33, is a delivery order for PROQUAD VIALS and has a completion date of February 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
The Department of Defense's Defense Logistics Agency (DLA) awarded a $20,799.75 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division to provide PROQUAD VIALS. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued up to $16,019.90 to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This Firm Fixed Price contract is for the supply of PROQUAD VIALS and has a period of performance through May 17, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which...